Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrahydrofuran SCHEMBL15993933 | 1.00 | ALDH1A1 (0.50) | ALDH1A1 | |
| SCHEMBL8530499 | 0.97 | ALDH1A1 (0.47) | ALDH1A1 | |
| Tetrahydrofuran SCHEMBL1896714 | 0.94 | ALDH1A1 (0.44) | ALDH1A1 | |
| Tetrahydrofuran SCHEMBL599386 | 0.92 | ALDH1A1 (0.42) | ALDH1A1 | |
| Tetrahydrofuran SCHEMBL27895752 | 0.92 | ALDH1A1 (0.42) | ALDH1A1 | |
| Hexane SCHEMBL6968999 | 0.89 | ALDH1A1 (0.40) | ALDH1A1 | |
| SCHEMBL971171 | 0.87 | TSHR (0.43) | — | |
| Dioxane SCHEMBL2947014 | 0.87 | TTR (0.43) | — | |
| Dioxane SCHEMBL6069108 | 0.84 | TTR (0.40) | — | |
| Hexane SCHEMBL7795120 | 0.83 | ALDH1A1 (0.35) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 139 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111285749-B | Improved method for preparing biphenyl derivative by micro-channel continuous flow | 山东冠森高分子材料科技股份有限公司 | 2021-04-20 | — | — | CN | claimed |
| CN-111285749-A | Improved method for preparing biphenyl derivative by micro-channel continuous flow | 阮楚君 | 2020-06-16 | — | — | CN | claimed |
| CN-110396161-A | Weary oxygen responsiveness micella with fluorescent characteristic and preparation method thereof | UNIV TONGJI | 2019-11-01 | — | — | CN | claimed |
| CN-106693829-A | Modified composite type surface active agent | 柏青龙 | 2017-05-24 | — | — | CN | claimed |
| CN-102603756-B | Rhodamine B sulfide compound and preparation method and applications of Rhodamine B sulfide compound | UNIV TIANJIN NORMAL | 2013-12-11 | — | — | CN | claimed |
| CN-102603756-A | Rhodamine B sulfide compound and preparation method and applications of Rhodamine B sulfide compound | UNIV TIANJIN NORMAL | 2012-07-25 | — | — | CN | claimed |
| CN-1166651-C | Anti-inflammatory and antineoplastic R-bis or glycophenylpropane isoselenazole substituted compound | ������ѧҩѧԺ | 2004-09-15 | — | — | CN | claimed |
| US-11912659-B2 | EBNA1 inhibitors and methods using same | THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY (US) | 2024-02-27 | — | — | US | disclosed |
| WO-2024003737-A1 | PROCESS AND INTERMEDIATES USEFUL FOR PREPARING NIRMATRELVIR | PFIZER INC. (US) | 2024-01-04 | — | — | WO | disclosed |
| WO-2023218201-A1 | IKK INHIBITORS | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2023-11-16 | — | — | WO | disclosed |
| US-20230340348-A1 | CO2-PHILIC CROSSLINKED POLYETHYLENE GLYCOL-BASED MEMBRANES FOR ACID AND SOUR GAS SEPARATIONS | SAUDI ARABIAN OIL COMPANY (SA) | 2023-10-26 | — | — | US | disclosed |
| US-11718805-B2 | CO2-philic crosslinked polyethylene glycol-based membranes for acid and sour gas separations | SAUDI ARABIAN OIL COMPANY (SA) | 2023-08-08 | — | — | US | disclosed |
| CN-116102666-A | 2-quaternary ammonium salt modified ethyl cellulose derivative and preparation method and application thereof | 湖北工程学院 | 2023-05-12 | — | — | CN | disclosed |
| CN-86101695-A | Prepare the method for β-Nei Xiananleikangshengsu and the application in medicine thereof | — | 1986-09-10 | — | — | CN | disclosed |
| EP-0018830-B1 | SPIROBENZOFURANONES, THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Takeda Chemical Industries, Ltd. (JP) | 1983-06-08 | — | — | EP | disclosed |
| EP-0018830-A2 | Spirobenzofuranones, their production and pharmaceutical compositions containing them | Takeda Chemical Industries, Ltd. (JP) | 1980-11-12 | — | — | EP | disclosed |
| US-4128719-A | FROM DIAMINOMALEONITRILE WITH CARBON DIOXIDE, SODIUM CYANIDE BASIC CATALYST | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1978-12-05 | — | — | US | disclosed |
| US-4093810-A | DIAMINOMALEONITRILE, CARBON DIOXIDE, POLAR SOLVENT, CATALYST | SAGAMI CHEMICAL RESEARCH CENTER (JA) | 1978-06-06 | — | — | US | disclosed |
| US-4080340-A | Nitroimidazoles | MERCK & CO., INC. (US) | 1978-03-21 | — | — | US | disclosed |
| US-4010176-A | Isoxazole substituted nitroimidazoles | MERCK & CO., INC. (US) | 1977-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11912659-B2 | EBNA1 inhibitors and methods using same | MLLT1, EBNA1BP2, MALT1 | ALDH1A1 3939/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.